Last Chance! Register for tomorrow’s CDC & FDA workshop - Newsletter : Health-Care - Home n Garden

Breaking News

Home / ACIP / ACIP Website Updates: info / CC license / CDC reports on AR burden / easy2post2 / Last Chance! Register for tomorrow’s CDC & FDA workshop

Last Chance! Register for tomorrow’s CDC & FDA workshop

, , , ,
Latest from CDC on Antibiotic Resistance (AR)

Join us Tomorrow: Drug Development Considerations for the Prevention of Healthcare-Associated Infections

It’s your last chance to register for tomorrow’s public workshop, Drug Development Considerations for the Prevention of Healthcare-Associated Infections.

Join CDC & the Food and Drug Administration (FDA) tomorrow, August 30, 2022, at 8:30 a.m. EDT to hear from experts on decolonization and pathogen reduction as a potential strategy to prevent infection and transmission of antimicrobial-resistant healthcare-associated pathogens. See the full speaker line-up and agenda at the registration website.

The event is open to the public, but registration is required. Register today before noon EDT.
Dark blue square with white text. There is a small design of several shades of blue hexagons in a pattern in the lower left corner. The logos for CDC and FDA are in the lower right corner. Drug Development Considerations for the Prevention of Healthcare-Associated Infections—Virtual Public Workshop Co-sponsored by CDC & FDA; Date: August 30, 2022; Time: 8:30 a.m. to 5 p.m.
Register

I just registered for a CDC & FDA workshop that may help generate more clinical research for new non-traditional therapeutics to prevent healthcare-associated infections and combat #AntimicrobialResistance. Join me: https://bit.ly/3xwoA2t 


Share On Twitter
CDC Facebook CDC Twitter CDC Streaming Health CDC Instagram

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  |  Unsubscribe

'; (function() { var dsq = document.createElement('script'); dsq.type = 'text/javascript'; dsq.async = true; dsq.src = '//' + disqus_shortname + '.disqus.com/embed.js'; (document.getElementsByTagName('head')[0] || document.getElementsByTagName('body')[0]).appendChild(dsq); })();

Pages

Popular Posts